PEB — Pacific Edge Share Price
0.000.00%
Last trade - 00:00- NZ$103.11m
- NZ$70.51m
- NZ$23.91m
- 13
- 24
- 63
- 26
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.54 | ||
| Price to Tang. Book | 2.59 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 4.74 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -73.16% | ||
| Return on Equity | -52.84% | ||
| Operating Margin | -142.55% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | NZ$m | 4.37 | 7.7 | 11.45 | 19.62 | 23.91 | 19.97 | 12.97 | 44.33% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Pacific Edge Limited is a global cancer diagnostics company. The Company is engaged in the development and commercialization of bladder cancer diagnostic and prognostic tests for patients presenting with hematuria or surveillance of recurrent disease. The Company operates through two segments: Commercial and Research. The Commercial segment is engaged in the sales, marketing, laboratory, and support operations to run the commercial businesses worldwide. The Research segment is engaged in the research and development of diagnostic and prognostic products for human cancer. The Company provides its suite of Cxbladder tests globally through its wholly owned laboratories in New Zealand and the United States. Its Cxbladder tests assist clinicians to safely de-intensify hematuria evaluation from low incidence populations; resolve diagnostic dilemmas and monitor patients for the recurrence of urothelial carcinoma. It operates in New Zealand, Australia, Singapore, and the United States.
Directors
- Chris Gallaher NEC
- Peter Meintjes CEO
- Grant Edward Gibson CFO
- David Levison CEX (54)
- Jackie Walker CEX
- Demi Stefanova COO
- Andrew McIntosh CIO
- Parry Guilford CSO
- Tony Lough VPR
- Brent Pownall VPR
- Jack Atchason OTH
- Mark Green IND
- Anna Stove IND
- Anatole Masfen NID
- Sarah Natalie Park NID
- Bryan Williams NID
- Last Annual
- March 31st, 2024
- Last Interim
- September 30th, 2024
- Incorporated
- February 27th, 2001
- Public Since
- February 12th, 2003
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- New Zealand Stock Exchange
- Shares in Issue
- 811,916,000
- Address
- Centre for Innovation 87 St David St,, DUNEDIN, 9016
- Web
- https://www.pacificedgedx.com
- Phone
- +64 35776733
- Auditors
- PricewaterhouseCoopers Chartered Accountants
Upcoming Events for PEB
Pacific Edge Ltd Annual Shareholders Meeting
FAQ
What is the Pacific Edge share price?
As of Today at 21:32 UTC, shares in Pacific Edge are trading at NZ$0.13. This share price information is delayed by 15 minutes.
How has the Pacific Edge share price performed this year?
Shares in Pacific Edge last closed at NZ$0.13 and the price had moved by +49.41% over the past 365 days. In terms of relative price strength the Pacific Edge share price has outperformed the ASX All Ordinaries Index by +47.83% over the past year.
What are the analyst and broker recommendations for Pacific Edge?
The overall consensus recommendation for Pacific Edge is Sell. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Pacific Edge dividend yield?
Pacific Edge does not currently pay a dividend.
Does Pacific Edge pay a dividend?
Pacific Edge does not currently pay a dividend.
When does Pacific Edge next pay dividends?
Pacific Edge does not currently pay a dividend.
How do I buy Pacific Edge shares?
To buy shares in Pacific Edge you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Pacific Edge?
As of the previous close price of NZ$0.13, shares in Pacific Edge had a market capitalisation of NZ$103.11m.
Where are Pacific Edge shares listed?
Here are the trading details for Pacific Edge:
- Country of listing: New Zealand
- Exchange: NZC
- Ticker Symbol: PEB
What kind of share is Pacific Edge?
Based on an overall assessment of its quality, value and momentum Pacific Edge is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Pacific Edge share price forecast for 2025?
The analyst consensus target price for shares in Pacific Edge is NZ$0.06. That is 48.82% below the last closing price of NZ$0.13.
Analysts covering Pacific Edge currently have a consensus Earnings Per Share (EPS) forecast of -NZ$0.04 for the next financial year.
Find out moreWhat is the trend in the Pacific Edge share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Pacific Edge. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -3.45%.
As of the last closing price of NZ$0.13, shares in Pacific Edge were trading +16.15% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Pacific Edge PE Ratio?
The Pacific Edge PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at NZ$0.13.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Pacific Edge?
Pacific Edge's management team is headed by:
- Chris Gallaher - NEC
- Peter Meintjes - CEO
- Grant Edward Gibson - CFO
- David Levison - CEX
- Jackie Walker - CEX
- Demi Stefanova - COO
- Andrew McIntosh - CIO
- Parry Guilford - CSO
- Tony Lough - VPR
- Brent Pownall - VPR
- Jack Atchason - OTH
- Mark Green - IND
- Anna Stove - IND
- Anatole Masfen - NID
- Sarah Natalie Park - NID
- Bryan Williams - NID